J&J profits surge thanks to COVID vaccine

By: Daniel J. Munoz
April 20, 2021 12:29 pm

The New Brunswick drugmaker's first-quarter income grew from nearly $5.8 billion in 2020 to $6.2 billion in 2021.

Get Essential Business News

First time registering your paid subscription? Click here

Having trouble with login?
Please contact service@bridgetowermedia.com.

Daniel J. Munoz

Daniel Munoz covers politics and state government for NJBIZ. You can contact him at dmunoz@njbiz.com.

NJBIZ Business Events